POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
1kcw CERULOPLASMIN
(Homo
sapiens)
4 / 7ALA A 114
TYR A 116
ASP A 127
HIS A 101
None
None
None
CU  A1052 (-3.2A)
0.90A19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
1kcw CERULOPLASMIN
(Homo
sapiens)
4 / 7ALA A 114
TYR A 116
TYR A 107
HIS A 101
None
None
None
CU  A1052 (-3.2A)
1.37A19.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
2c11 MEMBRANE COPPER
AMINE OXIDASE
(Homo
sapiens)
6 / 7ALA A 370
TYR A 372
TYR A 384
ASP A 386
TYR A 473
HIS A 522
PAQ  A 471 ( 3.2A)
None
PAQ  A 471 ( 3.6A)
PAQ  A 471 ( 2.6A)
PAQ  A 471 ( 4.5A)
CU  A1737 (-3.1A)
0.32A81.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
2vpj KELCH-LIKE PROTEIN
12
(Homo
sapiens)
4 / 7TYR A 332
TYR A 399
ASP A 400
HIS A 328
None
1.42A18.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
3hig AMILORIDE-SENSITIVE
AMINE OXIDASE
(Homo
sapiens)
6 / 7ALA A 357
TYR A 359
TYR A 371
ASP A 373
TYR A 463
HIS A 512
TPQ  A 461 ( 4.9A)
None
BRN  A 901 (-3.3A)
BRN  A 901 (-3.3A)
TPQ  A 461 ( 4.5A)
CU  A 801 (-3.2A)
0.68A40.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
3kq4 CUBILIN
(Homo
sapiens)
4 / 7ALA B1031
TYR B1032
ASP B 988
HIS B 954
None
None
CA  B2014 (-3.2A)
None
1.46A19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
(Homo
sapiens)
4 / 7ALA A 233
TYR A 235
TYR A 229
HIS A 260
None
1.32A18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
4cak INTEGRIN ALPHA-IIB
INTEGRIN BETA-3
(Homo
sapiens)
4 / 7ALA B 172
TYR B 178
ASP A 232
TYR A 234
None
1.20A20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
4u7t DNA
(CYTOSINE-5)-METHYLT
RANSFERASE 3A
(Homo
sapiens)
4 / 7ALA A 644
TYR A 660
TYR A 874
HIS A 677
None
1.45A20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
(Homo
sapiens)
4 / 7ALA A 288
TYR A 290
TYR A 284
HIS A 315
None
1.29A19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
5gs2 ANTI-MBP
ANTI-REPEBODY
(Homo
sapiens;
Mus
musculus)
4 / 7ALA D 107
TYR D 105
TYR H 181
TYR H 168
None
1.19A15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
5k0y EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT G
EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT I
(Homo
sapiens;
Oryctolagus
cuniculus)
4 / 7ALA T 267
TYR T 300
MET M 128
HIS T 284
None
1.39A17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
5ogs WD REPEAT AND
HMG-BOX DNA-BINDING
PROTEIN 1
(Homo
sapiens)
4 / 7ALA A 465
TYR A 458
ASP A 463
HIS A 480
None
1.32A20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_A_CLUA808_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
5xau LAMININ SUBUNIT
ALPHA-5
(Homo
sapiens)
4 / 7ALA A3205
TYR A3207
TYR A3216
ASP A3219
None
None
None
CA  A3401 (-3.9A)
1.19A23.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PNC_B_CLUB809_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
2c11 MEMBRANE COPPER
AMINE OXIDASE
(Homo
sapiens)
5 / 6ALA A 370
TYR A 384
ASP A 386
TYR A 473
HIS A 522
PAQ  A 471 ( 3.2A)
PAQ  A 471 ( 3.6A)
PAQ  A 471 ( 2.6A)
PAQ  A 471 ( 4.5A)
CU  A1737 (-3.1A)
0.31A81.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PNC_B_CLUB809_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
3hig AMILORIDE-SENSITIVE
AMINE OXIDASE
(Homo
sapiens)
5 / 6ALA A 357
TYR A 371
ASP A 373
TYR A 463
HIS A 512
TPQ  A 461 ( 4.9A)
BRN  A 901 (-3.3A)
BRN  A 901 (-3.3A)
TPQ  A 461 ( 4.5A)
CU  A 801 (-3.2A)
0.66A40.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_B_CLUB809_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
4cak INTEGRIN ALPHA-IIB
INTEGRIN BETA-3
(Homo
sapiens)
4 / 6ALA B 172
TYR B 178
ASP A 232
TYR A 234
None
1.22A20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNC_B_CLUB809_1
(COPPER AMINE
OXIDASE, LIVER
ISOZYME)
6dd3 CYTOSOLIC PURINE
5'-NUCLEOTIDASE
(Homo
sapiens)
4 / 6ALA A  58
TYR A  55
ASP A  54
TYR A 255
None
None
PO4  A 601 (-3.8A)
None
1.37A7.65